Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
04/13/2011 | CN102008588A Medicine composition for curing hepatic encephalopathy and hepatitis B |
04/13/2011 | CN102008585A Sihuang anti-dysentery effervescent particle and preparation method thereof |
04/13/2011 | CN102008566A Traditional Chinese medicinal preparation for curing acute icteric hepatitis |
04/13/2011 | CN102008557A Anti-influenza detoxifying capsules and preparation method thereof |
04/13/2011 | CN102008556A Qiqing Baidu effervescent granule and preparation method thereof |
04/13/2011 | CN102008549A Externally applied traditional Chinese medicine composition for curing mumps |
04/13/2011 | CN102008543A Chinese medicinal preparation for treating breast tuberculosis |
04/13/2011 | CN102008542A Compound neomycin sulfate soluble powder and production method thereof |
04/13/2011 | CN102008540A Active ingredient extracted from plant Ormosia fordiana Oliver and application thereof |
04/13/2011 | CN102008539A Medicinal composition for treating diseases such as vital myocarditis and dilated cardiomyopathy and preparation process thereof |
04/13/2011 | CN102008534A Antitubercular pharmaceutical composition containing balloonflower root extract |
04/13/2011 | CN102008533A Medicinal application and preparation method of shorthorned epimedium P.E |
04/13/2011 | CN102008531A Fufukang gel and preparation method thereof |
04/13/2011 | CN102008523A Process for preparing isatis powder |
04/13/2011 | CN102008513A Method for controlling high swine fever by using nose atomization microecological preparation |
04/13/2011 | CN102008501A Externally applied pharmaceutical composition as well as use method and application thereof |
04/13/2011 | CN102008490A Compound florfenicol injection for animal |
04/13/2011 | CN102008488A Triamcinolone acetonide ophthalmic preparation and preparation method thereof |
04/13/2011 | CN102008479A Cefaclor/montmorillonite composite material and preparation method thereof |
04/13/2011 | CN102008478A Tablet type capsule containing cefalexin tablets and ambroxol hydrochloride tablets |
04/13/2011 | CN102008467A Tablet capsule filled with amoxicillin tablets and ambroxol hydrochloride tablets |
04/13/2011 | CN102008459A Antibacterial agents |
04/13/2011 | CN102008452A Preparation technique of mezlocillin sodium freeze-dried powder |
04/13/2011 | CN102008447A Entecavir solid dispersion and preparation thereof |
04/13/2011 | CN102008445A Amoxicillin soluble powder as well as preparation method and application thereof |
04/13/2011 | CN102008436A Nocathiacin antibiotic medicament composition containing emulsifying agent |
04/13/2011 | CN102008431A Double-layer moxifloxacin suppository and preparation method thereof |
04/13/2011 | CN102008015A Orally-taken and externally-applied animal disinfection health care solution |
04/13/2011 | CN102007941A Application of Bdellovibrio nectophore in preparing bactericide for controlling red mouth disease of scophthalmus maximus |
04/13/2011 | CN102007940A Application of bdellovibrio mixture in preparing turbot red bill disease preventing and curing bactericide |
04/13/2011 | CN101756924B Sustained-release tablets of faropenem sodium |
04/13/2011 | CN101612179B Traditional Chinese medicine composition for treating hepatitis and liver cancer |
04/13/2011 | CN101590118B Chinese medicament for treating shingles and genital herpes |
04/13/2011 | CN101590026B Method for preparing Tiopronin enteric-coated tablet |
04/13/2011 | CN101574407B Drug for preventing cold and preparation method thereof |
04/13/2011 | CN101524331B Polysaccharide-liposome and preparation method and purpose thereof |
04/13/2011 | CN101485646B Andrographolide catablasm and preparation method thereof |
04/13/2011 | CN101406673B Oral liquid special for treating vital myocarditis of children |
04/13/2011 | CN101333246B Neutral B cell antigen epitope polypeptide of encephalitis b virus E protein and uses thereof |
04/13/2011 | CN101332281B Use of garlic volatile oil in preparing medicine for preventing and treating septicemic bordetella bacilli |
04/13/2011 | CN101323648B Extraction method and and purification method of Sanghuang mushroom polysaccharide |
04/13/2011 | CN101323594B Benzyl chloride tertiary amine double azole antimicrobial compounds, preparation and medical use thereof |
04/13/2011 | CN101322819B Agent for treating tinea manus and pedis and onychomycosis |
04/13/2011 | CN101317879B Medicament for treating eperythrozoon diseases of cattle, sheep and pig |
04/13/2011 | CN101302244B Production process of betulinic acid |
04/13/2011 | CN101209286B Method for preparing forsythol from forsythia suspensa leaves |
04/13/2011 | CN101085096B Method for extracting cordate houttuynia |
04/13/2011 | CN101028343B Total alkaloid of meadowrue corydalis and its purification and medicinal composition |
04/12/2011 | US7923559 7-(3-pyridyl)-1,7-diazaspiro[4.4]nonane; mania, anxiety, dyslexia, schizophrenia, depression, obsessive-compulsive disorders, Tourette's syndrome |
04/12/2011 | US7923554 HIV inhibiting 1,2,4-triazin-6-one derivatives |
04/12/2011 | US7923535 Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins |
04/12/2011 | US7923436 Methods and compounds for controlled release of recombinant parvovirus vectors |
04/12/2011 | US7923018 Vaccine |
04/12/2011 | CA2626498C Recombinant chimeric virus |
04/12/2011 | CA2504730C Cephem compounds |
04/12/2011 | CA2438304C Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
04/12/2011 | CA2354153C Compounds and methods for modulating activation of nf-.kappa.b |
04/12/2011 | CA2354054C Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
04/09/2011 | CA2716914A1 Novel crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt |
04/07/2011 | WO2011041551A1 Therapeutic antiviral peptides |
04/07/2011 | WO2011041350A2 Xenotropic mulv-related virus (xmrv) compositions and methods of use |
04/07/2011 | WO2011041325A2 Methods and compositions for the treatment of viral disorders |
04/07/2011 | WO2011040894A1 Topical compositions of opioid antagonists and methods for treating skin conditions therewith |
04/07/2011 | WO2011040600A1 NOVEL ANTIBACTERIAL AGENT TARGETING RESPONSE REGULATOR WaIR(YycF) |
04/07/2011 | WO2011040535A1 Hepatitis c virus vaccine composition |
04/07/2011 | WO2011040527A1 TRANSGENIC BIRD CAPABLE OF EXPRESSING α-GALACTOSE EPITOPE, VIRUS, AND VACCINE |
04/07/2011 | WO2011040526A1 VIRUS CAPABLE OF EXPRESSING α-GALACTOSE EPITOPE, AND METHOD FOR PRODUCTION OF VACCINE |
04/07/2011 | WO2011040386A1 Novel crystal of piperacillin sodium monohydrate |
04/07/2011 | WO2011040070A1 Oral composition for alleviation of ultraviolet radiation-induced damage |
04/07/2011 | WO2011040048A1 Virus inactivation sheet |
04/07/2011 | WO2011039735A2 Compounds with ddx3 inhibitory activity and uses thereof |
04/07/2011 | WO2011039574A1 The use of a herbal composition for the treatment of a person infected with hiv |
04/07/2011 | WO2011039353A1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers |
04/07/2011 | WO2011039221A2 Phosphoramidate derivatives of nucleosides |
04/07/2011 | WO2011038701A1 Hepatitis b virus antigen formulation for cell stimulation followed by therapeutic immunization |
04/07/2011 | WO2011038537A1 Methods and kits for the prediction, prevention and treatment of septicemia and septic shock |
04/07/2011 | WO2011038485A1 Crosslinked hydrogels and related method of preparation |
04/07/2011 | WO2011038473A1 Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of dna and chimeric virus vaccines |
04/07/2011 | WO2011018653A3 Treatment of viral infections |
04/07/2011 | WO2011013097A3 Polymer particles and uses thereof |
04/07/2011 | WO2010132758A3 Ospc-based diagnostic test for lyme disease |
04/07/2011 | WO2010129340A3 Novel photosensitizer formulations for oral administration |
04/07/2011 | WO2010111713A3 N-linked glycan biosynthesis modulators |
04/07/2011 | WO2010111436A3 Antiviral compounds and uses thereof |
04/07/2011 | WO2010105096A3 Modulation of human cytomegalovirus replication by micro-rna 132 (mir132), micro-rna 145 (mir145) and micro-rna 212 (mir212) |
04/07/2011 | WO2010090860A3 Methods and compositions for treating bacterial infection |
04/07/2011 | US20110082448 Pharmaceutical Compositions |
04/07/2011 | US20110082207 Inhibitors of Yeast Filamentous Growth and Method of Their Manufacture |
04/07/2011 | US20110082206 Heteroatom containing substituted fatty acids |
04/07/2011 | US20110082190 Nucleic Acids Encoding Anti-IL-12 Antibody |
04/07/2011 | US20110082186 Compositions for inhibiting gene expression and uses thereof |
04/07/2011 | US20110082182 Therapeutic antiviral peptides |
04/07/2011 | US20110082180 Antimicrobial compounds |
04/07/2011 | US20110082179 Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
04/07/2011 | US20110082161 Powders for reconstitution |
04/07/2011 | US20110082159 METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE |
04/07/2011 | US20110082132 [4-(1-amino-ehtyl) - cyclohexyl] -methyl-amine and [6-(1-amino-ehtyl) -tetrahydro-pyran-3-yl] -methyl-amine derivatives as antibacterials |
04/07/2011 | US20110082118 Onychomycosis Treatment Delivery System |
04/07/2011 | US20110082113 Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity |
04/07/2011 | US20110082112 Antiviral phosphinate compounds |